Published in

Elsevier, Journal of Pediatrics, 6(165), p. 1252-1254, 2014

DOI: 10.1016/j.jpeds.2014.08.010

Links

Tools

Export citation

Search in Google Scholar

Long-Term Growth Outcomes in Children Treated for Chronic Hepatitis C

This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Effects on linear growth were noted in children treated with peginterferon ± ribavirin in the Pediatric Study of Hepatitis C trial. Growth was further examined in a subset of patients followed for up to 6 years post-treatment. No long-term effects on height-for-age z scores were observed that could be attributed to hepatitis C virus treatment.